SE408177B - Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat - Google Patents

Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat

Info

Publication number
SE408177B
SE408177B SE7209886A SE988672A SE408177B SE 408177 B SE408177 B SE 408177B SE 7209886 A SE7209886 A SE 7209886A SE 988672 A SE988672 A SE 988672A SE 408177 B SE408177 B SE 408177B
Authority
SE
Sweden
Prior art keywords
hydroximethyl
procedure
preparation
phthalazone derivatives
phthalazone
Prior art date
Application number
SE7209886A
Other languages
English (en)
Swedish (sv)
Inventor
Sok
Original Assignee
Inoue Michiro
Masayuki Ishikawa
Tsuchiya Takashi
Shimamoto Takio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inoue Michiro, Masayuki Ishikawa, Tsuchiya Takashi, Shimamoto Takio filed Critical Inoue Michiro
Publication of SE408177B publication Critical patent/SE408177B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7209886A 1971-08-05 1972-07-28 Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat SE408177B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP46058643A JPS5116430B2 (nl) 1971-08-05 1971-08-05

Publications (1)

Publication Number Publication Date
SE408177B true SE408177B (sv) 1979-05-21

Family

ID=13090247

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7209886A SE408177B (sv) 1971-08-05 1972-07-28 Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE7210119A SE406587B (sv) 1971-08-05 1972-08-03 Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7210119A SE406587B (sv) 1971-08-05 1972-08-03 Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin

Country Status (23)

Country Link
US (1) US3864343A (nl)
JP (1) JPS5116430B2 (nl)
AR (3) AR194123A1 (nl)
AT (2) AT320658B (nl)
AU (2) AU461281B2 (nl)
BE (2) BE787138A (nl)
CA (2) CA999236A (nl)
CH (2) CH577980A5 (nl)
CS (2) CS180587B2 (nl)
DE (2) DE2237832A1 (nl)
DK (2) DK131857C (nl)
ES (2) ES405456A1 (nl)
FR (2) FR2150736B1 (nl)
GB (2) GB1404368A (nl)
HU (2) HU165815B (nl)
IE (2) IE36597B1 (nl)
LU (2) LU65856A1 (nl)
NL (2) NL7210369A (nl)
NO (1) NO134113C (nl)
SE (2) SE408177B (nl)
SU (2) SU577986A3 (nl)
YU (1) YU35245B (nl)
ZA (2) ZA725202B (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
DE102005011822A1 (de) * 2005-03-15 2006-09-21 Merck Patent Gmbh Phthalazinone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE687916A (nl) * 1965-10-12 1967-03-16

Also Published As

Publication number Publication date
DE2238566A1 (de) 1973-02-15
NO134113B (nl) 1976-05-10
AU4484372A (en) 1974-01-24
YU35245B (en) 1980-10-31
DK143159C (da) 1981-11-16
AU461018B2 (en) 1975-05-15
YU201372A (en) 1980-04-30
AR197156A1 (es) 1974-03-15
AU4494072A (en) 1974-01-31
CA966489A (en) 1975-04-22
GB1404367A (en) 1975-08-28
IE36597L (en) 1973-02-05
DK143159B (da) 1981-07-06
CS180587B2 (en) 1978-01-31
NL151261B (nl) 1976-11-15
JPS4826781A (nl) 1973-04-09
ZA725203B (en) 1973-04-25
FR2150735B1 (nl) 1976-04-16
NL7210369A (nl) 1973-02-07
BE787138A (fr) 1972-12-01
CS180588B2 (en) 1978-01-31
CH580081A5 (nl) 1976-09-30
LU65855A1 (nl) 1973-01-15
ZA725202B (en) 1973-04-25
AT317233B (de) 1974-08-26
BE787139A (fr) 1972-12-01
DK131857C (da) 1976-02-16
SU513622A3 (ru) 1976-05-05
HU165815B (nl) 1974-11-28
SU577986A3 (ru) 1977-10-25
AT320658B (de) 1975-02-25
HU163726B (nl) 1973-10-27
AR197089A1 (es) 1974-03-15
AU461281B2 (en) 1975-05-22
AR194123A1 (es) 1973-06-22
FR2150735A1 (nl) 1973-04-13
FR2150736B1 (nl) 1976-04-16
ES405555A1 (es) 1975-07-01
IE36598B1 (en) 1976-12-08
CH577980A5 (nl) 1976-07-30
NO134113C (nl) 1976-08-18
NL7210370A (nl) 1973-02-07
GB1404368A (en) 1975-08-28
FR2150736A1 (nl) 1973-04-13
DK131857B (da) 1975-09-15
SE406587B (sv) 1979-02-19
IE36598L (en) 1973-02-05
LU65856A1 (nl) 1973-01-15
ES405456A1 (es) 1975-07-16
JPS5116430B2 (nl) 1976-05-24
US3864343A (en) 1975-02-04
DE2237832A1 (de) 1973-02-15
CA999236A (en) 1976-11-02
IE36597B1 (en) 1976-12-08

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE417318B (sv) Forfarande for framstellning av oxofurylesterderivat av penicillin
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE7510790L (sv) Forfarande for framstellning av 2- eller 3-cefemderivat
SE387948B (sv) Forfarande for framstellning av tiofen
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner